The German drugmaker is searching for a new leader
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71.
LONDON — The co-founders of the Covid-19 vaccine developer BioNTech plan to leave the biotech to start a new mRNA-focused company, the German drugmaker said Tuesday.
Ugur Sahin and Özlem Türeci, who are married, will transition to the as-of-yet unnamed company by the end of the year, with a focus on researching and developing next-generation mRNA medicines.
BioNTech will be giving certain rights to its mRNA technology to the new company, while picking up a minority stake in it.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71.
